Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services | News
Search Refinements

Contract Services News

View news from other Pharmaceutical sectors:
1-15 of 2364 results
Sunovion to sell asthma and allergy products to Covis Pharma
Sunovion Pharmaceuticals has agreed to sell the US market rights to its ciclesonide products Alvesco (ciclesonide) Inhalation Aerosol, Omnaris (ciclesonide) Nasal Spray, and Zetonna (ciclesonide) Nasal Aerosol to Covis Pharma.
Contract Research & Services > Contract Services > News
Emergent BioSolutions to buy Sanofi’s smallpox vaccine business for $125m
By PBR Staff Writer
Emergent BioSolutions has agreed to acquire Sanofi’s smallpox vaccine business for around $125m.
Contract Research & Services > Contract Services > News
Shield, Ewopharma partner to commercialize Feraccru in Switzerland
Shield Therapeutics and Ewopharma have entered into an exclusive sale, supply, distribution and marketing agreement for Feraccru in Switzerland.
Contract Research & Services > Contract Services > News
Alexion signs funding deal with NICE and NHS England for Strensiq
Alexion Pharmaceuticals has signed a national funding agreement with the National Institute for Health and Care Excellence (NICE) and the National Health Service (NHS) England based on a Managed Access Agreement (MAA), which provides access to Strensiq (asfotase alfa) for patients in England with pediatric-onset hypophosphatasia (HPP), regardless of their current age.
Contract Research & Services > Contract Services > News
eFFECTOR partners with Pfizer, Merck to evaluate combination of two immuno-oncology agents
eFFECTOR Therapeutics has entered into a clinical collaboration and supply agreement with Pfizer and Merck to evaluate the combination of two immuno-oncology agents in patients with microsatellite stable colorectal cancer (CRC).
Contract Research & Services > Contract Services > News
Immune Pharmaceuticals signs deal to regain global rights for Ceplene
Immune Pharmaceuticals has signed an agreement with Mylan company Meda to repurchase assets relating to Ceplene, including the right to commercialize it in Europe and to register and commercialize in several other countries.
Contract Research & Services > Contract Services > News
Pfizer to commercialize Basilea's Cresemba drug in Europe
Basilea Pharmaceutica International has signed a license agreement with Pfizer for its marketed antifungal Cresemba (isavuconazole) to treat life-threatening invasive mold infections.
Contract Research & Services > Contract Services > News
OBI Pharma to acquire Threshold's TH-3424 small-molecule prodrug
Taiwan-based OBI Pharma has agreed to acquire Threshold Pharmaceuticals' TH-3424, a novel small-molecule prodrug that selectively targets cancers overexpressing the enzyme aldo-keto reductase 1c3 (AKR1C3).
Contract Research & Services > Contract Services > News
ImmunoGen and Sanofi amend license deals
ImmunoGen and an affiliate of Sanofi have amended their license agreements to cover all compounds developed by the latter using ImmunoGen’s technology.
Contract Research & Services > Contract Services > News
Debiopharm acquires ImmunoGen’s ADC IMGN529/Debio 1562
Debiopharm International has acquired ImmunoGen's IMGN529/Debio 1562, a clinical-stage anti-CD37 ADC for the treatment of patients with B-cell malignancies, such as non-Hodgkin lymphomas (NHL).
Contract Research & Services > Contract Services > News
INC Research, inVentiv agree to merge in $4.6bn deal
By PBR Staff Writer
INC Research has agreed to acquire US-based contract research organization (CRO) inVentiv Health in all stock deal worth nearly $4.6bn.
Contract Research & Services > Contract Services > News
Novartis licenses CAR-T patents from Celyad
Celyad has granted Novartis a non-exclusive license for its allogeneic TCR-deficient CAR-T cells patents.
Contract Research & Services > Contract Services > News
Akebia expands anemia drug collaboration with Otsuka
By PBR Staff Writer
US-based Akebia Therapeutics has expanded its collaboration with Japan's Otsuka Pharmaceutical on an anemia treatment.
Contract Research & Services > Contract Services > News
Immune Pharmaceuticals licenses cancer treatment's Latin America rights to Pint
Immune Pharmaceuticals has entered into a letter of intent with Pint Pharma regarding license and commercializion of Ceplene in Latin America.
Contract Research & Services > Contract Services > News
PureTech signs licensing and equity deal with Novartis to advance clinical stage mTORC1 programs
PureTech Health has signed a licensing and equity agreement with Novartis to advance two clinical-stage programs targeting the mechanistic target of rapamycin complex 1 (mTORC1) pathway.
Contract Research & Services > Contract Services > News
1-15 of 2364 results